Skip to main content

Table 7 Effect of injection intratumorally with 109 cells/ml of S. cerevisiae and S. cerevisiae-GNSs on AST, ALT, urea, and creatinine concentrations in the negative, positive, and treatment groups

From: Gold nanoparticles combined baker’s yeast as a successful approach for breast cancer treatment

Parameters

AST

ALT

Urea

Creatinine

Groups

Negative control (normal)

289.0 ± 27.6n.s,N.S

246.3 ± 19.8###,N.S

50.6 ± 0.4n.s,N.S

0.45 ± 0.06#,N.S

Positive control (tumor)

411.7 ± 10.9n.s,+++

406.2 ± 32.6***,+

70.7 ± 4.7n.s,++

0.85 ± 0.07*,+

S. cerevisiae 109 (yeast group)

208.0 ± 3.8n.s,###

200.6 ± 34n.s,#

46.3 ± 5.2n.s,##

0.46 ± 0.02n.s,#

S. cerevisiae–GNSs

273.3 ± 5.9n.s,##

215.4 ± 14.3n.s,#

40.1 ± 4.7n.s,###

0.31 ± 0.05n.s,#

  1. Significance relative to normal: *P ≤ 0.05, ***P ≤ 0.001, and n.s P ≥ 0.05; significance relative to tumor: #P ≤ 0.05, ##P ≤ 0.01, ###P ≤ 0.001; significance relative to yeast: +P ≤ 0.05, ++P ≤ 0.01, +++P ≤ 0.001 and N.SP ≥ 0.05